Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A computational model to describe multi-regional brain architecture during neurodegeneration in Alzheimer's disease.

Scientific reports·2026
Same author

Advances in the drug treatment of Alzheimer's disease: pathophysiology and mechanisms of action.

BMJ (Clinical research ed.)·2026
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Clinical Manifestations.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Marie Emilie Tuil1, Bshaier Allehyany2, Paul Edison2,3

  • 1Imperial College London, London, United Kingdom.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
概括
此摘要是机器生成的。

阿尔茨海默病 (AD) 中的星球细胞反应因阶段和区域而异,一种亲炎症途径早期出现. 似乎是一个关键的神经毒性因素,与粉样蛋白和天体细胞活动相互作用.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经科学是一个神经科学.
  • 神经病理学神经病理学
  • 生物标志物研究 生物标志物研究

背景情况:

  • 星系细胞和微质细胞的反应性与阿尔茨海默病 (AD) 病原发生有关,但研究结果往往是矛盾的.
  • 证据表明微质反应的多样性,从神经保护性到神经毒性.
  • 天体细胞-微细胞相互作用表明,天体细胞在AD中可能表现出类似的可变反应.

研究的目的:

  • 为了研究星状细胞反应,AD生物标志物和认知衰退之间的关系.
  • 了解星细胞反应如何影响AD病理在不同的疾病阶段和大脑区域.
  • 评估阿尔茨海默氏症中天体细胞反应的阶段和特定区域的模式.

主要方法:

  • 来自ADNI数据库的323名参与者的分析,按粉样蛋白-β (Aβ) 和认知状态 (AD,MCI) 分层.
  • 脑脊液 (CSF) 生物标志物的测量 (YKL-40,GAP-43,Aβ1-42,T-tau,p-tau181),MRI和PET扫描 (18F-AV45,18F-FDG). 脑脊液的生物标志物 (YKL-40,GAP-43,Aβ1-42,T-tau,p-tau181),MRI和PET扫描 (18F-AV45,18F-FDG). 脑脊液的生物标志物 (YKL-40,GAP-43,Aβ1-42,T-tau,p-tau181),MRI和PET扫描 (18F-AV45,18F-FDG). 脑脊液的生物标志物 (YKL-40,GAP-43,Aβ1-42,T-tau,p-tau181),MRI和PET扫描 (18F-AV45,18F-FDG) 的测量.
  • 使用Pearson相关性和基于voxel的线性回归来评估生物标志物关系和空间模式的统计分析.

主要成果:

  • 在所有参与者群体中,tau水平,GAP-43和YKL-40之间发现了显著的相关性.
  • 根据疾病阶段不同,YKL-40与GAP-43和Aβ1-42有显著的关联.
  • 基于Voxel的分析揭示了18F-AV45和YKL-40的Braak样模式,特别是在早期的MCI中.

结论:

  • YKL-40相关性表明AD的依赖阶段的星细胞反应,最初与Aβ和tau相关,然后主要与tau相关.
  • 随着AD的进展,突触功能障碍与tau和YKL-40相关,观察到类似于Braak的模式.
  • 被认为是阿尔茨海默氏症的主要神经毒性标志,与粉样蛋白和天体细胞反应有协同作用.